Global API Contract Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global API Contract Manufacturing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.
API Contract Manufacturing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global API Contract Manufacturing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Central nervous system are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for API Contract Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, API Contract Manufacturing key companies include AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd, Merck＆Co.，Inc, Novartis AG, Piramal Pharma Solutions, Ranbaxy Laboratories Ltd., Reddy's Laboratories Ltd and Sandoz-Lek-Biochemie, etc. AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd are top 3 players and held % share in total in 2022.
API Contract Manufacturing can be divided into Commercial Manufacturing and Clinical Manufacturing, etc. Commercial Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
API Contract Manufacturing is widely used in various fields, such as Oncology, Central nervous system, Cardiovascular disorder and Infectious diseases, etc. Oncology provides greatest supports to the API Contract Manufacturing industry development. In 2022, global % share of API Contract Manufacturing went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global API Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck＆Co.，Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd
Segment by Type
Commercial Manufacturing
Clinical Manufacturing
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the API Contract Manufacturing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, API Contract Manufacturing introduction, etc. API Contract Manufacturing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of API Contract Manufacturing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
API Contract Manufacturing report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global API Contract Manufacturing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oncology and Central nervous system are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for API Contract Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, API Contract Manufacturing key companies include AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd, Merck＆Co.，Inc, Novartis AG, Piramal Pharma Solutions, Ranbaxy Laboratories Ltd., Reddy's Laboratories Ltd and Sandoz-Lek-Biochemie, etc. AstraZeneca Plc, BoehringerIngelhein GmbH, GlaxoSmithKline Pharmaceuticals Ltd are top 3 players and held % share in total in 2022.
API Contract Manufacturing can be divided into Commercial Manufacturing and Clinical Manufacturing, etc. Commercial Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
API Contract Manufacturing is widely used in various fields, such as Oncology, Central nervous system, Cardiovascular disorder and Infectious diseases, etc. Oncology provides greatest supports to the API Contract Manufacturing industry development. In 2022, global % share of API Contract Manufacturing went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global API Contract Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
AstraZeneca Plc
BoehringerIngelhein GmbH
GlaxoSmithKline Pharmaceuticals Ltd
Merck＆Co.，Inc
Novartis AG
Piramal Pharma Solutions
Ranbaxy Laboratories Ltd.
Reddy's Laboratories Ltd
Sandoz-Lek-Biochemie
Sun Pharmaceutical Industries Ltd
Teva Pharmaceuticals Industries Ltd
Segment by Type
Commercial Manufacturing
Clinical Manufacturing
Segment by Application
Oncology
Central nervous system
Cardiovascular disorder
Infectious diseases
Pulmonary disorders
Metabolic disorder
Gastrointestinal disorders
Musculoskeletal disorders
Genitourinary disorders
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the API Contract Manufacturing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, API Contract Manufacturing introduction, etc. API Contract Manufacturing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of API Contract Manufacturing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices